{"ticker": {"uuid": "ea16cc1a-ab8c-4c4b-9ff3-300b68acead2", "symbol": "IRIX", "name": "IRIDEX Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Form 4 IRIDEX Corporation For: 14 July By Investing.com", "summary": "This article announces the filing of a Form 4 for IRIDEX Corporation on July 14. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in ownership of the company's restricted stock. The publication pr", "url": "https://ca.investing.com/news/stock-market-news/form-4-iridex-corporation-for-14-july-93CH-4733934", "source_name": "Investing.com Canada", "published_at": "2026-07-14T21:17:45", "published_display": "14 Jul 2026 21:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX CORP (IRIX) grants CFO 30K RSUs and 170K options", "summary": "IRIDEX CORP (IRIX) awarded its CFO, Romeo R. Dizon, 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares. The RSUs vest in three equal annual installments starting July 10, 2027, and the stock option, with an exercise price of $1.10 per share, expires on Jul", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-8dbb65e8f2d0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:17:45", "published_display": "14 Jul 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Form 13D/A IRIDEX CORP For: 13 July By Investing.com", "summary": "This article reports on the filing of Form 13D/A for IRIDEX CORP on July 13th, as sourced by Investing.com. It is a brief announcement without further details within the body of the text, indicating the release of a regulatory filing for the specified company.", "url": "https://ng.investing.com/news/stock-market-news/form-13da-iridex-corp-for-13-july-93CH-2597710", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:12:36", "published_display": "14 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPVmFsbm1Yb2lTbGtzOER6ZEg1NnU3T1RFeldDUWdGTnhBUDZBMjlQd3o5ZjRYWGYxcW9IS1NDYWxURi0tSTF1X0E0SFJhQWFNb1lnU1FLWktlVkRSZEhWTDFsRFpycy0tQlVvWndkWUFFQ3k3aU4xbFNnRGxnbnRLLWNMS0JJZ2lweTk3RTI5MUJIckU0a2o1SmtLVl9DNDZXMzhDTGtUMV9sMk1CYUlQQW9mWGtTbEFxQUxJUXQ1cUhnSXJyWVUtYlRrdEo4QQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T21:50:00+00:00", "published_display": "13 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Corp (Nasdaq: IRIX) investor group reports 29.92% ownership stake", "summary": "An investor group comprising Novel Inspiration International Co., Ltd., Xinpo Venture Capital Co., Ltd., and Shih-Yao David Lin has reported a 29.92% beneficial ownership stake in Iridex Corp. As of July 10, 2026, Mr. Lin beneficially owns 6,738,238 shares, including common stock", "url": "https://www.stocktitan.net/sec-filings/IRIX/schedule-13d-a-iridex-corp-amended-major-shareholder-report-f0c9f69d3268.html", "source_name": "Stock Titan", "published_at": "2026-07-13T22:11:34", "published_display": "13 Jul 2026 22:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 IRIDEX Corporation For: 8 July By Investing.com", "summary": "This article announces the filing of a Form 4 for IRIDEX Corporation on July 8th, as reported by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their ownership of the company", "url": "https://ng.investing.com/news/stock-market-news/form-4-iridex-corporation-for-8-july-93CH-2591102", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T17:10:17", "published_display": "08 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest", "summary": "Novel Inspiration International Co., Ltd., a major shareholder in IRIDEX (IRIX), received 111,997 shares of common stock as a quarterly interest payment on a Convertible Promissory Note. Following this non-cash transaction, Novel Inspiration directly holds 551,429 shares, which a", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-9fa8d717386a.html", "source_name": "Stock Titan", "published_at": "2026-07-08T12:39:44", "published_display": "08 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp updates retinal laser portfolio as ophthalmology demand evolves", "summary": "IRIDEX Corp (ISIN US4627191006) is continuously refining its retinal laser systems and glaucoma treatment technologies to meet the evolving demands of ophthalmology practices. The company focuses on a niche market of eye-care specialists, providing equipment for minimally invasiv", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/iridex-corp-updates-retinal-laser-portfolio-as-ophthalmology-demand/69716475", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T18:11:35", "published_display": "07 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corporation (IRIX) Slides Amid Light Trading, Key Support Levels in Focus - Arms Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNRW5ZLW5EcUZqSEtqdVNicHcyZEVROFdlUVkzcDJtRlVDZVdMWlRxQk1zQjl3WHZoWWZtRWNrbmdwSXdSYWNvTEF0eTQySDB6SkVyVkdabXRnNDdTTWdVTUFXYUpmQzU2d01oZW45OVRiOEozVXpYUGFTMFJ4Q1pLcjNPV3d1ajFESVZ3Mzk2UmMzc1ZUTXdzNUJQSkwtak1PeXV2R1F2cC1ianNadGdINGc1VzNaZ1VEYURHNS1B?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T00:46:08+00:00", "published_display": "07 Jul 2026 00:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis of IRIDEX Corp (IRIX), noting its current valuation score of 9.10 and ranking 40th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -5.90, which is significantly below its recent high and slightly ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T03:14:13", "published_display": "19 Jun 2026 03:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date", "summary": "IRIDEX Corporation has adjourned its 2026 annual meeting of stockholders, originally held on June 12, 2026, without conducting any business. The meeting is now scheduled to reconvene on July 10, 2026, at 8:00 a.m. Pacific Time at the company's Mountain View headquarters. The reco", "url": "https://www.stocktitan.net/sec-filings/IRIX/8-k-iridex-corp-reports-material-event-dda913766a6b.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:14:13", "published_display": "18 Jun 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Institutional Confidence", "summary": "The article analyzes the institutional confidence in IRIDEX Corp (IRIX), noting its current score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. Institutional shareholding proportion increased by 16.49% quarter-over-quarter, with James Simons identifi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:14:13", "published_display": "18 Jun 2026 09:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "IRIDEX Corp (IRIX) currently has a price momentum score of 6.78, placing it in the 101st position out of 204 in the Healthcare Equipment & Supplies industry. The stock is trading between a resistance level of $1.25 and a support level of $1.03, suggesting a range-bound swing trad", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/technical", "source_name": "TradingKey", "published_at": "2026-06-18T03:41:23", "published_display": "18 Jun 2026 03:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for IRIDEX Corp (IRIX), highlighting its current earnings forecast score, analyst ratings, and peer comparison within the Healthcare Equipment & Supplies industry. It also includes anticipated revenue and EPS for upcoming quarters, notin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T19:41:23", "published_display": "17 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of IRIDEX Corp (IRIX) focusing on its dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years and reports no data regarding stock splits. The piece is from TradingKey and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T17:41:00", "published_display": "17 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed breakdown of IRIDEX Corp's (IRIX) revenue by business segment and geographical region. As of the latest update on Monday, April 6th, the company's revenue is primarily driven by its Retina and G6 segments, with significant contributions from the U", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T17:41:00", "published_display": "17 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations", "summary": "IRIDEX CORP President and CEO Patrick Mercer reported a tax-withholding disposition of 3,990 shares of Common Stock at $1.12 per share to satisfy tax obligations, rather than through an open-market sale. Following this transaction, Mercer directly holds 368,784 shares. This type ", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-647a1303a053.html", "source_name": "Stock Titan", "published_at": "2026-06-16T23:39:35", "published_display": "16 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes", "summary": "IRIDEX Corp's CFO, Romeo R. Dizon, reported a tax-related share withholding where 2,691 shares of common stock were disposed of at $1.12 per share to satisfy a tax obligation. This was a tax-withholding disposition, not an open-market sale, and after the transaction, Dizon direct", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-c4d281b1c63f.html", "source_name": "Stock Titan", "published_at": "2026-06-16T23:39:35", "published_display": "16 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com", "summary": "Iridex CFO Romeo Dizon recently acquired 975 shares of IRIDEX CORP (NASDAQ:IRIX) common stock for a total of $1,110, at a price of $1.1386 per share. This transaction increases his direct holdings to 135,975 shares. The purchase comes as IRIDEX stock shows a 19% return over the p", "url": "https://uk.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1110-in-company-stock-93CH-4728690", "source_name": "Investing.com UK", "published_at": "2026-06-15T20:09:40", "published_display": "15 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $1,110 in company stock", "summary": "Iridex CFO Romeo R. Dizon recently purchased 975 shares of the company's common stock for $1,110. This transaction increases his direct holdings to 135,975 shares. The purchase occurred as the stock trades near $1.14, having delivered a 19% return over the past year, and analysts", "url": "https://m.uk.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1110-in-company-stock-93CH-4728690?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-15T19:09:36", "published_display": "15 Jun 2026 19:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy", "summary": "IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, purchased 975 common shares in an open-market transaction at an average price of $1.1386 per share. This transaction increases his direct holdings to 135,975 common shares. The filing, a Form 4, indicates a neutral impact and", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-63d06307c8f5.html", "source_name": "Stock Titan", "published_at": "2026-06-15T15:40:28", "published_display": "15 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX)", "summary": "Romeo Dizon, CFO of IRIDEX Corp (IRIX), recently purchased 1,675 shares, increasing his total holdings to 135,000 shares. This transaction is part of a larger trend of insider buying at IRIDEX, with 50 insider buys and no sells over the past year. Despite the buying activity, the", "url": "https://www.gurufocus.com/news/8914517/insider-buying-romeo-dizon-acquires-additional-shares-of-iridex-corp-irix", "source_name": "GuruFocus", "published_at": "2026-06-12T20:40:35", "published_display": "12 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $1,909 in company stock", "summary": "Iridex CFO Romeo R. Dizon recently acquired 1,675 shares of the company's common stock for $1,909, increasing his direct ownership to 135,000 shares. The stock has gained 21.63% over six months and is considered undervalued by InvestingPro, despite a recent Q1 2026 revenue miss b", "url": "https://www.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1909-in-company-stock-93CH-4740230", "source_name": "Investing.com", "published_at": "2026-06-12T19:40:35", "published_display": "12 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase", "summary": "IRIDEX Corp. CFO Romeo R. Dizon reported an open-market purchase of 1,675 shares of company common stock at $1.14 per share on June 11, 2026. Following this transaction, Dizon directly owns 135,000 common shares. The acquisition signifies a modest increase to his existing positio", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-80ff1b6d8d1e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:40:35", "published_display": "12 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,688 in company stock", "summary": "Iridex CFO Romeo R. Dizon purchased 2,400 shares of the company's common stock for $2,688 on June 8, 2026, increasing his direct holdings to 133,325 shares. This transaction occurred as the stock trades near $1.11, with analysts projecting a potential 148% upside to a target of $", "url": "https://www.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-2688-in-company-stock-93CH-4733164", "source_name": "Investing.com", "published_at": "2026-06-10T05:39:16", "published_display": "10 Jun 2026 05:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference", "summary": "Iridex Corporation (Nasdaq: IRIX) announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17, at 4:00 pm PT, with a live and archived webcast available on the company\u2019s website. Iridex is a global leader ", "url": "https://www.globenewswire.com/news-release/2026/06/09/3309324/0/en/iridex-to-present-at-the-planet-microcap-las-vegas-2026-conference.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T19:40:17", "published_display": "09 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com", "summary": "Iridex CFO Romeo R. Dizon recently purchased 2,400 shares of the company's common stock for $2,688, bringing his total direct holdings to 133,325 shares. This transaction occurred as IRIX shares trade near $1.11, with analysts suggesting a significant potential upside. Despite a ", "url": "https://ng.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-2688-in-company-stock-93CH-2550111", "source_name": "Investing.com Nigeria", "published_at": "2026-06-09T18:09:16", "published_display": "09 Jun 2026 18:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Watch Iridex\u2019s June 17 Planet MicroCap talk live from Las Vegas", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOWmtnN2QzUGFwX0dIeENhanRmdUFvVXJNUkNBSWxJaEw0YVdnS1hjeDlrbzY5M0pheUpOQ0tkMHVVWElDWEtRZzdfSG1SRGI0OExoLWZXWUtvZUxycGJveVBJTWpoZ1N0UGZoZXFaTzNEWkdoSzFsb3lDYXZUV3ZheVBqZURPNGpURWlnaVVsVnV4TUgyTEt0NVNxaGhhejdyQ1VmS0lCQ29XVkJxejh2Vg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Dizon purchases $2,899 of common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOd3BIODB6Ri1lTDlkRC1LcG9Nal9VakVlRE9qWEoxWUo3WkVDUkh2VkRnUDNFRlBSU21WUERWcjlmMDl5OFVDNWFUa0JQemZsSnhYYkdTZTFJb3d4OW1YZFAyM3RocnA5ZnVuMFdKUTRwMXo4NnlDU3phVkJYWng5M1NiTXR3OEtpNlRHWGh1Uk1QdjZzdEtlTVp5WHhKOTY1X29XRUhDZEN0S3VMSzMyWWZ3?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNV9OQ2RaYzd5ams0Qmw0WkhtSVVZbjI0eG9aUmZKN3JRUEdKalJYcjRrQlFnU1hONlVTeU43XzBRb2pncklrM1cwRDZFUXNIRmFkV1RMcEpaSFlsenB2VlZvbzRXUUtic0M2akNLSVU2WmtxZEZMcXVHdWpSOWRXVlVwLWN3MTczVGJWaUlXTEhtODgyakV0aEYwbTA3QThFNTI3WnNKTkg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,808 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPalZzLVlJeG9ZT2NEYWJSMFlOVlFFeUNZWGRQZy1ZV21ZNmlvOWttZV92Y1RHN3gtcU5UWTFQbERscG1YUERRRDBuWC01X1k4NXBmM21tQkNreW1SbjNrZElXeEhqc01Xd1R3YnFBempVOGlPTWVvdFJjWXl3alVtdnZXM3YxQXdmWGc4dzhzdXZ2TXd2ekhoeWF6WC1vNkt2R294Sl9CWFAyQTRwZ2ViX3NDNFM?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A. G. P. Maintains IRIDEX(IRIX.US) With Buy Rating, Maintains Target Price $2.75", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOOVJlNTBFU1VJSHNSczAzZjlWRnRBbVNjMWcyT2JBTl9pOFgwMmplWVNxYzdMOG02bFQ0cTB0STd4ME9KdGY3Z01WOENtdUFsTkFUbml6ckg2SGZUNE1BSmxaQ0ZiOWxBTi1NNURNaGFOYkp1Y2V3ZW9zX0ZaZEluME1pZlpFRWFfSmZZUTE5TTdUS3NLTTBLQ2lxUkMtQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iridex-corp-irix-q1-2026-050019049.html", "source_name": "GuruFocus.com", "published_at": "2026-05-20T05:00:19+00:00", "published_display": "20 May 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex (IRIX) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/d187e3c0-a111-380c-9ff9-2021b903ea1e/iridex-%28irix%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-19T22:03:20+00:00", "published_display": "19 May 2026 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iridex-q1-earnings-snapshot-201143997.html", "source_name": "Associated Press", "published_at": "2026-05-19T20:11:43+00:00", "published_display": "19 May 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corporation Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOdnpQMDBZeEw5S0JhOE54ck0tN09ab2U5LUpUUF9ubHVuYk1mZFNETFpkRWd1ZzBlejhvWUNaUTN5eFMxTWVYcG9RcVZ0Wmw0TjhWRkhLV2NLaGR5aUVFenI2VWd4UWJ0VGQxN29rRk1uT0JjOU9VNEdKOFhaVEswb1JLRTI2MlN1X3ViWUFtYlhXTktUR1g5VVVtem04RXlxX3c?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSzNpc3dZb21WNG5sQ2ZjOWpxYnQ0eC13aW5mS3ctQnZ6Wl9UT3ViRlVydmRzNENQMnJ3dHQ5SkVCQ2liUnY3SG53UkF1RGZZSDhUeFVTUW5ZUjVvWHhnSE9HUC1LYUNoTTNRcC1tNUtHOUYyVndlYllRc09YczNWVzRCZzRRMGNtMEZGbWtHUjhBLXpzN2FPZEZxUFVsX0dvT282TTM3RHdtNmt3T3JIVnZxLXUwdG9rdTVkMUdoTWs?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex to Report First Quarter 2026 Financial Results on May 19, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/iridex-report-first-quarter-2026-200500466.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T20:05:00+00:00", "published_display": "05 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "The Zacks Analyst Blog  Microsoft, AbbVie, BHP,  CBL & Associates Properties and IRIDEX", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-analyst-blog-microsoft-abbvie-062700004.html", "source_name": "Zacks", "published_at": "2026-04-20T06:27:00+00:00", "published_display": "20 Apr 2026 06:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "More than 1,800 eye care members gain pricing access to Iridex lasers", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNM0YxMEFQVEFCT3AtTnE5X004cVFldnlmT0NnWDYwMzVkcE9CVnc5UlY4b2d1TkZDaWdCZ0ZHbHhIdlFIdnQ1TnhqN1JwdVdhUHZzNkk1UFpkQmM1YV9WQV9MZWVodHpKZGE2WVFvdnM0SVk1cWxVaHJLZ2UtdGs0WmZ6dmNsNWpMckVCMTFoenJaeXQ1YnhNTXlmQlpIei1tcHZYakhGVG9HeEwzRmJ3UDhvYXdNWnpCUkk0MjJB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRXFKZnRoU2M5RXhVOVNKSWJGdVdodnlVQThGT0V6RFppOGpudFBMX0NEenNKcHRZSnRUYmxzWERMWDhFVjdmcnBMRWFmR2xDWDNGWHVWTGxQTjNoWlg3ZVpYb005OUtRNUlRRW0ta1FJMU9HbnpwTHNLX0hWblNIeUYxVktVUXVYVFF5QUxsS1BVWmFjVTZrUHp6N1lfWjlwZzczRWQ2SzcwTHZqejFBbm1sR2FMM2xmYURmSkFhTVM4SGFZaXROV1FhN1RVM2NENGNxSEZINFpVT3o2T2NINkJIYVVKZk54M2pUaWwta0hEZ3Nkb2dQWUpkVl9KWkk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Iridex Comments on Recent Stock Price Volatility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2025-03-14T07:00:00+00:00", "published_display": "14 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQlhBbGEzQnJiaW5XTU4ySFFtLUNVRk1wOE5kUkpLMjlxVGlQM0FFV3lQYWNyRTdZLURqNDRUT1RKSlBSY0VlQ1lvdnlTanlzbXY5N0Z5NVFVaXNabl9uUTJfOE9vU0RVcHpSYmlXTEdrZTBnUWNHY05DUUJrWnUyeGhPRXRPSkhGQjdua2o2bXVLWHQ3cHdhclJ3ZnNuVEFxZ0hLYm9ZMVo?oc=5", "source_name": "Stock Titan", "published_at": "2024-11-19T08:00:00+00:00", "published_display": "19 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Form 4 IRIDEX Corporation For: 14 July By Investing.com", "summary": "This article announces the filing of a Form 4 for IRIDEX Corporation on July 14. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in ownership of the company's restricted stock. The publication pr", "url": "https://ca.investing.com/news/stock-market-news/form-4-iridex-corporation-for-14-july-93CH-4733934", "source_name": "Investing.com Canada", "published_at": "2026-07-14T21:17:45", "published_display": "14 Jul 2026 21:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX CORP (IRIX) grants CFO 30K RSUs and 170K options", "summary": "IRIDEX CORP (IRIX) awarded its CFO, Romeo R. Dizon, 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares. The RSUs vest in three equal annual installments starting July 10, 2027, and the stock option, with an exercise price of $1.10 per share, expires on Jul", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-8dbb65e8f2d0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:17:45", "published_display": "14 Jul 2026 20:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13D/A IRIDEX CORP For: 13 July By Investing.com", "summary": "This article reports on the filing of Form 13D/A for IRIDEX CORP on July 13th, as sourced by Investing.com. It is a brief announcement without further details within the body of the text, indicating the release of a regulatory filing for the specified company.", "url": "https://ng.investing.com/news/stock-market-news/form-13da-iridex-corp-for-13-july-93CH-2597710", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T00:12:36", "published_display": "14 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPVmFsbm1Yb2lTbGtzOER6ZEg1NnU3T1RFeldDUWdGTnhBUDZBMjlQd3o5ZjRYWGYxcW9IS1NDYWxURi0tSTF1X0E0SFJhQWFNb1lnU1FLWktlVkRSZEhWTDFsRFpycy0tQlVvWndkWUFFQ3k3aU4xbFNnRGxnbnRLLWNMS0JJZ2lweTk3RTI5MUJIckU0a2o1SmtLVl9DNDZXMzhDTGtUMV9sMk1CYUlQQW9mWGtTbEFxQUxJUXQ1cUhnSXJyWVUtYlRrdEo4QQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T21:50:00+00:00", "published_display": "13 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Corp (Nasdaq: IRIX) investor group reports 29.92% ownership stake", "summary": "An investor group comprising Novel Inspiration International Co., Ltd., Xinpo Venture Capital Co., Ltd., and Shih-Yao David Lin has reported a 29.92% beneficial ownership stake in Iridex Corp. As of July 10, 2026, Mr. Lin beneficially owns 6,738,238 shares, including common stock", "url": "https://www.stocktitan.net/sec-filings/IRIX/schedule-13d-a-iridex-corp-amended-major-shareholder-report-f0c9f69d3268.html", "source_name": "Stock Titan", "published_at": "2026-07-13T22:11:34", "published_display": "13 Jul 2026 22:11", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 IRIDEX Corporation For: 8 July By Investing.com", "summary": "This article announces the filing of a Form 4 for IRIDEX Corporation on July 8th, as reported by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their ownership of the company", "url": "https://ng.investing.com/news/stock-market-news/form-4-iridex-corporation-for-8-july-93CH-2591102", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T17:10:17", "published_display": "08 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novel Inspiration gains IRIDEX (IRIX) shares as quarterly note interest", "summary": "Novel Inspiration International Co., Ltd., a major shareholder in IRIDEX (IRIX), received 111,997 shares of common stock as a quarterly interest payment on a Convertible Promissory Note. Following this non-cash transaction, Novel Inspiration directly holds 551,429 shares, which a", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-9fa8d717386a.html", "source_name": "Stock Titan", "published_at": "2026-07-08T12:39:44", "published_display": "08 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp updates retinal laser portfolio as ophthalmology demand evolves", "summary": "IRIDEX Corp (ISIN US4627191006) is continuously refining its retinal laser systems and glaucoma treatment technologies to meet the evolving demands of ophthalmology practices. The company focuses on a niche market of eye-care specialists, providing equipment for minimally invasiv", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/iridex-corp-updates-retinal-laser-portfolio-as-ophthalmology-demand/69716475", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T18:11:35", "published_display": "07 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corporation (IRIX) Slides Amid Light Trading, Key Support Levels in Focus - Arms Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNRW5ZLW5EcUZqSEtqdVNicHcyZEVROFdlUVkzcDJtRlVDZVdMWlRxQk1zQjl3WHZoWWZtRWNrbmdwSXdSYWNvTEF0eTQySDB6SkVyVkdabXRnNDdTTWdVTUFXYUpmQzU2d01oZW45OVRiOEozVXpYUGFTMFJ4Q1pLcjNPV3d1ajFESVZ3Mzk2UmMzc1ZUTXdzNUJQSkwtak1PeXV2R1F2cC1ianNadGdINGc1VzNaZ1VEYURHNS1B?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T00:46:08+00:00", "published_display": "07 Jul 2026 00:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis of IRIDEX Corp (IRIX), noting its current valuation score of 9.10 and ranking 40th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -5.90, which is significantly below its recent high and slightly ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T03:14:13", "published_display": "19 Jun 2026 03:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) adjourns 2026 shareholder meeting, sets July 10 reconvene date", "summary": "IRIDEX Corporation has adjourned its 2026 annual meeting of stockholders, originally held on June 12, 2026, without conducting any business. The meeting is now scheduled to reconvene on July 10, 2026, at 8:00 a.m. Pacific Time at the company's Mountain View headquarters. The reco", "url": "https://www.stocktitan.net/sec-filings/IRIX/8-k-iridex-corp-reports-material-event-dda913766a6b.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:14:13", "published_display": "18 Jun 2026 20:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Institutional Confidence", "summary": "The article analyzes the institutional confidence in IRIDEX Corp (IRIX), noting its current score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. Institutional shareholding proportion increased by 16.49% quarter-over-quarter, with James Simons identifi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:14:13", "published_display": "18 Jun 2026 09:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "IRIDEX Corp (IRIX) currently has a price momentum score of 6.78, placing it in the 101st position out of 204 in the Healthcare Equipment & Supplies industry. The stock is trading between a resistance level of $1.25 and a support level of $1.03, suggesting a range-bound swing trad", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/technical", "source_name": "TradingKey", "published_at": "2026-06-18T03:41:23", "published_display": "18 Jun 2026 03:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for IRIDEX Corp (IRIX), highlighting its current earnings forecast score, analyst ratings, and peer comparison within the Healthcare Equipment & Supplies industry. It also includes anticipated revenue and EPS for upcoming quarters, notin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T19:41:23", "published_display": "17 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of IRIDEX Corp (IRIX) focusing on its dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years and reports no data regarding stock splits. The piece is from TradingKey and", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T17:41:00", "published_display": "17 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed breakdown of IRIDEX Corp's (IRIX) revenue by business segment and geographical region. As of the latest update on Monday, April 6th, the company's revenue is primarily driven by its Retina and G6 segments, with significant contributions from the U", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-irix/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T17:41:00", "published_display": "17 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CEO surrenders 3,990 shares to cover tax obligations", "summary": "IRIDEX CORP President and CEO Patrick Mercer reported a tax-withholding disposition of 3,990 shares of Common Stock at $1.12 per share to satisfy tax obligations, rather than through an open-market sale. Following this transaction, Mercer directly holds 368,784 shares. This type ", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-647a1303a053.html", "source_name": "Stock Titan", "published_at": "2026-06-16T23:39:35", "published_display": "16 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO has 2,691 shares withheld to pay taxes", "summary": "IRIDEX Corp's CFO, Romeo R. Dizon, reported a tax-related share withholding where 2,691 shares of common stock were disposed of at $1.12 per share to satisfy a tax obligation. This was a tax-withholding disposition, not an open-market sale, and after the transaction, Dizon direct", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-c4d281b1c63f.html", "source_name": "Stock Titan", "published_at": "2026-06-16T23:39:35", "published_display": "16 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com", "summary": "Iridex CFO Romeo Dizon recently acquired 975 shares of IRIDEX CORP (NASDAQ:IRIX) common stock for a total of $1,110, at a price of $1.1386 per share. This transaction increases his direct holdings to 135,975 shares. The purchase comes as IRIDEX stock shows a 19% return over the p", "url": "https://uk.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1110-in-company-stock-93CH-4728690", "source_name": "Investing.com UK", "published_at": "2026-06-15T20:09:40", "published_display": "15 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $1,110 in company stock", "summary": "Iridex CFO Romeo R. Dizon recently purchased 975 shares of the company's common stock for $1,110. This transaction increases his direct holdings to 135,975 shares. The purchase occurred as the stock trades near $1.14, having delivered a 19% return over the past year, and analysts", "url": "https://m.uk.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1110-in-company-stock-93CH-4728690?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-15T19:09:36", "published_display": "15 Jun 2026 19:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy", "summary": "IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, purchased 975 common shares in an open-market transaction at an average price of $1.1386 per share. This transaction increases his direct holdings to 135,975 common shares. The filing, a Form 4, indicates a neutral impact and", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-63d06307c8f5.html", "source_name": "Stock Titan", "published_at": "2026-06-15T15:40:28", "published_display": "15 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX)", "summary": "Romeo Dizon, CFO of IRIDEX Corp (IRIX), recently purchased 1,675 shares, increasing his total holdings to 135,000 shares. This transaction is part of a larger trend of insider buying at IRIDEX, with 50 insider buys and no sells over the past year. Despite the buying activity, the", "url": "https://www.gurufocus.com/news/8914517/insider-buying-romeo-dizon-acquires-additional-shares-of-iridex-corp-irix", "source_name": "GuruFocus", "published_at": "2026-06-12T20:40:35", "published_display": "12 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $1,909 in company stock", "summary": "Iridex CFO Romeo R. Dizon recently acquired 1,675 shares of the company's common stock for $1,909, increasing his direct ownership to 135,000 shares. The stock has gained 21.63% over six months and is considered undervalued by InvestingPro, despite a recent Q1 2026 revenue miss b", "url": "https://www.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-1909-in-company-stock-93CH-4740230", "source_name": "Investing.com", "published_at": "2026-06-12T19:40:35", "published_display": "12 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase", "summary": "IRIDEX Corp. CFO Romeo R. Dizon reported an open-market purchase of 1,675 shares of company common stock at $1.14 per share on June 11, 2026. Following this transaction, Dizon directly owns 135,000 common shares. The acquisition signifies a modest increase to his existing positio", "url": "https://www.stocktitan.net/sec-filings/IRIX/form-4-iridex-corp-insider-trading-activity-80ff1b6d8d1e.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:40:35", "published_display": "12 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,688 in company stock", "summary": "Iridex CFO Romeo R. Dizon purchased 2,400 shares of the company's common stock for $2,688 on June 8, 2026, increasing his direct holdings to 133,325 shares. This transaction occurred as the stock trades near $1.11, with analysts projecting a potential 148% upside to a target of $", "url": "https://www.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-2688-in-company-stock-93CH-4733164", "source_name": "Investing.com", "published_at": "2026-06-10T05:39:16", "published_display": "10 Jun 2026 05:39", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference", "summary": "Iridex Corporation (Nasdaq: IRIX) announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17, at 4:00 pm PT, with a live and archived webcast available on the company\u2019s website. Iridex is a global leader ", "url": "https://www.globenewswire.com/news-release/2026/06/09/3309324/0/en/iridex-to-present-at-the-planet-microcap-las-vegas-2026-conference.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T19:40:17", "published_display": "09 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com", "summary": "Iridex CFO Romeo R. Dizon recently purchased 2,400 shares of the company's common stock for $2,688, bringing his total direct holdings to 133,325 shares. This transaction occurred as IRIX shares trade near $1.11, with analysts suggesting a significant potential upside. Despite a ", "url": "https://ng.investing.com/news/insider-trading-news/iridex-cfo-romeo-dizon-buys-2688-in-company-stock-93CH-2550111", "source_name": "Investing.com Nigeria", "published_at": "2026-06-09T18:09:16", "published_display": "09 Jun 2026 18:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Watch Iridex\u2019s June 17 Planet MicroCap talk live from Las Vegas", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOWmtnN2QzUGFwX0dIeENhanRmdUFvVXJNUkNBSWxJaEw0YVdnS1hjeDlrbzY5M0pheUpOQ0tkMHVVWElDWEtRZzdfSG1SRGI0OExoLWZXWUtvZUxycGJveVBJTWpoZ1N0UGZoZXFaTzNEWkdoSzFsb3lDYXZUV3ZheVBqZURPNGpURWlnaVVsVnV4TUgyTEt0NVNxaGhhejdyQ1VmS0lCQ29XVkJxejh2Vg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Dizon purchases $2,899 of common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOd3BIODB6Ri1lTDlkRC1LcG9Nal9VakVlRE9qWEoxWUo3WkVDUkh2VkRnUDNFRlBSU21WUERWcjlmMDl5OFVDNWFUa0JQemZsSnhYYkdTZTFJb3d4OW1YZFAyM3RocnA5ZnVuMFdKUTRwMXo4NnlDU3phVkJYWng5M1NiTXR3OEtpNlRHWGh1Uk1QdjZzdEtlTVp5WHhKOTY1X29XRUhDZEN0S3VMSzMyWWZ3?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNV9OQ2RaYzd5ams0Qmw0WkhtSVVZbjI0eG9aUmZKN3JRUEdKalJYcjRrQlFnU1hONlVTeU43XzBRb2pncklrM1cwRDZFUXNIRmFkV1RMcEpaSFlsenB2VlZvbzRXUUtic0M2akNLSVU2WmtxZEZMcXVHdWpSOWRXVlVwLWN3MTczVGJWaUlXTEhtODgyakV0aEYwbTA3QThFNTI3WnNKTkg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex CFO Romeo Dizon buys $2,808 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPalZzLVlJeG9ZT2NEYWJSMFlOVlFFeUNZWGRQZy1ZV21ZNmlvOWttZV92Y1RHN3gtcU5UWTFQbERscG1YUERRRDBuWC01X1k4NXBmM21tQkNreW1SbjNrZElXeEhqc01Xd1R3YnFBempVOGlPTWVvdFJjWXl3alVtdnZXM3YxQXdmWGc4dzhzdXZ2TXd2ekhoeWF6WC1vNkt2R294Sl9CWFAyQTRwZ2ViX3NDNFM?oc=5", "source_name": "Investing.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A. G. P. Maintains IRIDEX(IRIX.US) With Buy Rating, Maintains Target Price $2.75", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOOVJlNTBFU1VJSHNSczAzZjlWRnRBbVNjMWcyT2JBTl9pOFgwMmplWVNxYzdMOG02bFQ0cTB0STd4ME9KdGY3Z01WOENtdUFsTkFUbml6ckg2SGZUNE1BSmxaQ0ZiOWxBTi1NNURNaGFOYkp1Y2V3ZW9zX0ZaZEluME1pZlpFRWFfSmZZUTE5TTdUS3NLTTBLQ2lxUkMtQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iridex-corp-irix-q1-2026-050019049.html", "source_name": "GuruFocus.com", "published_at": "2026-05-20T05:00:19+00:00", "published_display": "20 May 2026 05:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex (IRIX) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/d187e3c0-a111-380c-9ff9-2021b903ea1e/iridex-%28irix%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-19T22:03:20+00:00", "published_display": "19 May 2026 22:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/iridex-q1-earnings-snapshot-201143997.html", "source_name": "Associated Press", "published_at": "2026-05-19T20:11:43+00:00", "published_display": "19 May 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRIDEX Corporation Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOdnpQMDBZeEw5S0JhOE54ck0tN09ab2U5LUpUUF9ubHVuYk1mZFNETFpkRWd1ZzBlejhvWUNaUTN5eFMxTWVYcG9RcVZ0Wmw0TjhWRkhLV2NLaGR5aUVFenI2VWd4UWJ0VGQxN29rRk1uT0JjOU9VNEdKOFhaVEswb1JLRTI2MlN1X3ViWUFtYlhXTktUR1g5VVVtem04RXlxX3c?oc=5", "source_name": "Market source", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSzNpc3dZb21WNG5sQ2ZjOWpxYnQ0eC13aW5mS3ctQnZ6Wl9UT3ViRlVydmRzNENQMnJ3dHQ5SkVCQ2liUnY3SG53UkF1RGZZSDhUeFVTUW5ZUjVvWHhnSE9HUC1LYUNoTTNRcC1tNUtHOUYyVndlYllRc09YczNWVzRCZzRRMGNtMEZGbWtHUjhBLXpzN2FPZEZxUFVsX0dvT282TTM3RHdtNmt3T3JIVnZxLXUwdG9rdTVkMUdoTWs?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex to Report First Quarter 2026 Financial Results on May 19, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/iridex-report-first-quarter-2026-200500466.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T20:05:00+00:00", "published_display": "05 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Zacks Analyst Blog  Microsoft, AbbVie, BHP,  CBL & Associates Properties and IRIDEX", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/zacks-analyst-blog-microsoft-abbvie-062700004.html", "source_name": "Zacks", "published_at": "2026-04-20T06:27:00+00:00", "published_display": "20 Apr 2026 06:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "More than 1,800 eye care members gain pricing access to Iridex lasers", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNM0YxMEFQVEFCT3AtTnE5X004cVFldnlmT0NnWDYwMzVkcE9CVnc5UlY4b2d1TkZDaWdCZ0ZHbHhIdlFIdnQ1TnhqN1JwdVdhUHZzNkk1UFpkQmM1YV9WQV9MZWVodHpKZGE2WVFvdnM0SVk1cWxVaHJLZ2UtdGs0WmZ6dmNsNWpMckVCMTFoenJaeXQ1YnhNTXlmQlpIei1tcHZYakhGVG9HeEwzRmJ3UDhvYXdNWnpCUkk0MjJB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRXFKZnRoU2M5RXhVOVNKSWJGdVdodnlVQThGT0V6RFppOGpudFBMX0NEenNKcHRZSnRUYmxzWERMWDhFVjdmcnBMRWFmR2xDWDNGWHVWTGxQTjNoWlg3ZVpYb005OUtRNUlRRW0ta1FJMU9HbnpwTHNLX0hWblNIeUYxVktVUXVYVFF5QUxsS1BVWmFjVTZrUHp6N1lfWjlwZzczRWQ2SzcwTHZqejFBbm1sR2FMM2xmYURmSkFhTVM4SGFZaXROV1FhN1RVM2NENGNxSEZINFpVT3o2T2NINkJIYVVKZk54M2pUaWwta0hEZ3Nkb2dQWUpkVl9KWkk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex Comments on Recent Stock Price Volatility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2025-03-14T07:00:00+00:00", "published_display": "14 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQlhBbGEzQnJiaW5XTU4ySFFtLUNVRk1wOE5kUkpLMjlxVGlQM0FFV3lQYWNyRTdZLURqNDRUT1RKSlBSY0VlQ1lvdnlTanlzbXY5N0Z5NVFVaXNabl9uUTJfOE9vU0RVcHpSYmlXTEdrZTBnUWNHY05DUUJrWnUyeGhPRXRPSkhGQjdua2o2bXVLWHQ3cHdhclJ3ZnNuVEFxZ0hLYm9ZMVo?oc=5", "source_name": "Stock Titan", "published_at": "2024-11-19T08:00:00+00:00", "published_display": "19 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 85, "total_relevant": 54, "sentiment_summary": {"positive": 15, "negative": 0, "neutral": 39, "score": 55, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 13.75, "count": 25}, {"event": "earnings", "label": "Earnings", "weight": 9.84, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.1, "latest_week": "2026-07-10", "one_week_move": -2.7, "four_week_move": -1.8, "twelve_week_move": 3.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.245667, "market_dynamics_buy_signal": false, "relative_strength": -19.63936, "fair_value_gap": -35.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.0168, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.7% over one week, -1.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 12}, {"label": "Market source", "count": 10}, {"label": "TradingKey", "count": 6}, {"label": "Investing.com", "count": 5}, {"label": "GlobeNewswire", "count": 4}, {"label": "Investing.com Nigeria", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 43}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 25}, {"label": "Earnings", "count": 20}, {"label": "Deals and strategy", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "43", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.7% over one week, -1.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Form 4 IRIDEX Corporation For: 14 July By Investing.com"}], "updated_at": "2026-07-16T08:07:37.821289+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}